IR
57
2
INTC
25
2
CCL
70
3
BWA
60
4
EMR
59
2
BRK.B
34
-2
RL
83
4
AMGN
26
-4
DD
36
3
FIS
65
9
LB
41
-28
APD
40
5
T
68
-3
KLAC
65
2
KR
65
-4
O
33
-4
CRM
54
2
GME
81
4
MUR
34
3
ESS
33
-3
IR
57
2
INTC
25
2
CCL
70
3
BWA
60
4
EMR
59
2
BRK.B
34
-2
RL
83
4
AMGN
26
-4
DD
36
3
FIS
65
9
LB
41
-28
APD
40
5
T
68
-3
KLAC
65
2
KR
65
-4
O
33
-4
CRM
54
2
GME
81
4
MUR
34
3
ESS
33
-3
Financhill
Back

Collegium Pharmaceutical Stock Predictions

Top investors are buying this "unlisted" stock

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
45

COLL
Collegium Pharmaceutical

Last Price:
$28.91
Seasonality Move:
-1.69%

7 Day Trial

ALL ACCESS PASS

$ 7

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Collegium Pharmaceutical Stock Forecast

  • Over the next 52 weeks, Collegium Pharmaceutical has on average historically risen by 23.7% based on the past 9 years of stock performance.
  • Collegium Pharmaceutical has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
  • Is Collegium Pharmaceutical Stock Undervalued?
    The current Collegium Pharmaceutical [COLL] share price is $28.89. The Score for COLL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • COLL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Collegium Pharmaceutical Stock Go Up Next Year?

  • Over the next 52 weeks, Collegium Pharmaceutical has on average historically risen by 23.7% based on the past 9 years of stock performance.

Collegium Pharmaceutical Stock Rating

Sell
45
Collegium Pharmaceutical (COLL) is a Sell

Is Collegium Pharmaceutical overpriced?

  • Collegium Pharmaceutical has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

Collegium Pharmaceutical Stock Price History

Is COLL stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COLL is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
collegiumpharma.com

52-Week Data

52-Week High:
42.29
52-Week Low:
23.23

Prediction Charts

Market Cap:
928.6M
Price in USD:
28.89
Volume:
561.7K
Beta:
0.82

Technical Analysis

SMA50:
28.21
SMA100:
29.53
SMA200:
32.41
52-Wk Change:
-23.69%

Stock Predictions

  • Is Collegium Pharmaceutical stock public?
    Yes, Collegium Pharmaceutical is a publicly traded company.
  • What is the Collegium Pharmaceutical stock quote today?
    The Collegium Pharmaceutical stock price is 28.89 USD today.
  • How to buy Collegium Pharmaceutical stock online?
    You can buy Collegium Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-22 27.24 26.89 27.95 26.83
Apr-23 27.20 25.99 27.48 25.87
Apr-24 26.07 26.78 26.94 25.98
Apr-25 26.60 26.79 27.09 26.22
Apr-28 26.98 26.87 27.35 26.67
Apr-29 26.78 27.60 27.70 26.68
Apr-30 27.23 27.00 27.54 26.93
May-1 26.71 27.06 27.10 26.16
May-2 27.41 27.65 28.19 27.01
May-5 27.56 27.78 28.19 27.52
May-6 27.77 27.03 27.80 26.78
May-7 27.18 27.05 27.34 26.72
May-8 27.08 27.27 27.97 26.81
May-9 29.66 28.89 29.66 27.84

Collegium Pharmaceutical Earnings

Collegium Pharmaceutical Earnings Report: Per Share Collegium Pharmaceutical Earnings Q1 Q2 Q3 and Q4 last year and next year.

Collegium Pharmaceutical Forecast Revenue Growth

Collegium Pharmaceutical Stock Analysis: Historical quarterly revenues per share for Collegium Pharmaceutical and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.16 per share, an increase this year of $0.72 per share, and an increase next year of $0.12 per share.

* Collegium Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.